Niagen Bioscience (NAGE) Net Income towards Common Stockholders: 2011-2024
Historic Net Income towards Common Stockholders for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $8.6 million.
- Niagen Bioscience's Net Income towards Common Stockholders rose 143.77% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 1275.69%. This contributed to the annual value of $8.6 million for FY2024, which is 273.15% up from last year.
- As of FY2024, Niagen Bioscience's Net Income towards Common Stockholders stood at $8.6 million, which was up 273.15% from -$4.9 million recorded in FY2023.
- In the past 5 years, Niagen Bioscience's Net Income towards Common Stockholders registered a high of $8.6 million during FY2024, and its lowest value of -$27.1 million during FY2021.
- Moreover, its 3-year median value for Net Income towards Common Stockholders was -$4.9 million (2023), whereas its average is -$5.0 million.
- Per our database at Business Quant, Niagen Bioscience's Net Income towards Common Stockholders tumbled by 36.15% in 2021 and then spiked by 273.15% in 2024.
- Niagen Bioscience's Net Income towards Common Stockholders (Yearly) stood at -$19.9 million in 2020, then crashed by 36.15% to -$27.1 million in 2021, then soared by 31.33% to -$18.6 million in 2022, then soared by 73.49% to -$4.9 million in 2023, then surged by 273.15% to $8.6 million in 2024.